Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Oct 6, 2021
- Accession no.
- 0001447362-21-000233
- Filed
- Oct 6, 2021
- Trade date
- Oct 4-5, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 18 non-derivative transactions. Open-market sales total $308.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | Common Stock | SSaleDisposed | −496 | $60.26F2 | −$29,888.96 | 133,465 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −169 | $60.88F4 | −$10,288.72 | 133,296 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −101 | $62.38F5 | −$6,300.38 | 133,195 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −67 | $62.89F6 | −$4,213.63 | 133,128 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −497 | $60.26F2 | −$29,949.22 | 156,303 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −168 | $60.88F4 | −$10,227.84 | 156,135 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −102 | $62.38F5 | −$6,362.76 | 156,033 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −66 | $62.89F6 | −$4,150.74 | 155,967 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −497 | $60.26F2 | −$29,949.22 | 143,702 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −168 | $60.88F4 | −$10,227.84 | 143,534 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −102 | $62.38F5 | −$6,362.76 | 143,432 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −67 | $62.89F6 | −$4,213.63 | 143,365 | Indirect | |
| Oct 5, 2021 | Common Stock | SSaleDisposed | −300 | $62.05F9 | −$18,615 | 132,828 | Indirect | |
| Oct 5, 2021 | Common Stock | SSaleDisposed | −534 | $62.81F10 | −$33,540.54 | 132,294 | Indirect | |
| Oct 5, 2021 | Common Stock | SSaleDisposed | −300 | $62.05F9 | −$18,615 | 155,667 | Indirect | |
| Oct 5, 2021 | Common Stock | SSaleDisposed | −533 | $62.81F10 | −$33,477.73 | 155,134 | Indirect | |
| Oct 5, 2021 | Common Stock | SSaleDisposed | −300 | $62.05F9 | −$18,615 | 143,065 | Indirect | |
| Oct 5, 2021 | Common Stock | SSaleDisposed | −533 | $62.81F10 | −$33,477.73 | 142,532 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $59.660 to $60.555, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $60.710 to $61.680, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $61.720 to $62.700, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $62.870 to $62.910, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $61.440 to $62.430, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $62.500 to $63.145, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.